Mater Private Network is expanding its radiotherapy service in Limerick, giving public and private cancer patients across the Mid-West access to a broader range of specialist expertise and…
The Irish Cancer Society was the only Patient Advocacy Group from Ireland selected to present its innovative patient partnership model at ASCO 2026, the world's largest oncology conference.
Johnson & Johnson has partnered with Myeloma Ireland as lead sponsor of the gold medal-winning ‘Rooted in Resilience’ garden at Bloom 2026.
OxygenCare has announced the Irish launch of the GE Carestation 850 Anaesthesia Delivery System at the College of Anaesthesiologists of Ireland Annual Congress.
Presented at the All-Island Cancer Summit, the Cancer Dashboard for Ireland report outlines growing pressures on Ireland’s cancer system and identifies key priorities for the next National Cancer Strategy.
Gilead Sciences and Kite have announced the reimbursement of two CAR T-cell therapies in Ireland for eligible adult patients with certain relapsed or refractory blood cancers.
The European Commission has approved AKEEGA® (niraparib and abiraterone acetate) for patients with BRCA1/2-mutated metastatic hormone-sensitive prostate cancer, following Phase 3 data showing a significant delay in disease progression and an early survival benefit.
The Irish Cancer Society provided almost 30,000 free lifts to and from cancer treatment in 2025, alongside thousands of counselling sessions, support line conversations, and nights of end-of-life nursing care, according to new figures released ahead of Daffodil Day.
HPV Network Ireland has launched on International HPV Awareness Day, bringing together health and advocacy organisations to strengthen awareness of HPV and the cancers it can cause.
Researchers from across Ireland were honoured at the Irish Cancer Society Research Awards 2026, recognising advances in radiotherapy innovation and men’s cancer survivorship care.
You’re all caught up.
